Stocktoria
Bluejay Diagnostics, Inc. BJDX
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2021-11-10
Bluejay Diagnostics, Inc. statistics & valuation
Market cap$3.0M
P / B0.5×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | — | — | — | 19.6% | — |
| Operating margin | — | — | — | -3741.5% | — |
| Net margin | — | — | — | -3733.1% | — |
| FCF margin | — | — | — | -3590.1% | — |
| Return on assets | -96.2% | -115.9% | -204.5% | -68.8% | -16.6% |
| Return on equity | -114.6% | -134.7% | -343.8% | -80.6% | -17.1% |
| Current ratio | 4.88 | 6.05 | 1.82 | 7.19 | 32.43 |
Source: SEC EDGAR filings · CIK 0001704287 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.